Interaksi Hidrokodon dan klorfeniramin dan Lemboreksant

Hidrokodon dan klorfeniramin dan Lemboreksant: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Hidrokodon dan klorfeniramin (Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release) · berlaku sejak 2025-06-26

Mayor

…ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; MEDICATION ERRORS; CYTOCHROME P450 3A4 INTERACTION; CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; INTERACTION WITH ALCOHOL; NEONATAL OPIOID WITHDRAWAL SYNDROME WARNING: ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION;…

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Avoid the use of Hydrocodone Polistirex and Chlorpheniramine Polistirex in patients taking benzodiazepines, other CNS depressants, or alcohol [ see Warning and Precautions (5.8) , Drug Interactions (7.5) ].

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Avoid concurrent use of Hydrocodone Polistirex and Chlorpheniramine Polistirex with alcohol or other central nervous system depressants because additional impairment of central nervous system performance may occur [ see Warnings and Precautions (5.8) ].

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Dari label Lemboreksant (DAYVIGO) · berlaku sejak 2025-02-24

Moderat

CNS Depressant Effects and Daytime Impairment: Impairs alertness and motor coordination including morning impairment.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Risk increases with dose and use with other central nervous system (CNS) depressants.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Co-administration with other CNS depressants (e.g., benzodiazepines, opioids, tricyclic antidepressants, alcohol) increases the risk of CNS depression, which can cause daytime impairment.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Dosage adjustments of DAYVIGO and of concomitant CNS depressants may be necessary when administered together because of potentially additive effects.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Minor

CNS Depressant Effects and Daytime Impairment DAYVIGO is a central nervous system (CNS) depressant that can impair daytime wakefulness even when used as prescribed.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.